1. Anik, S. T., Mcrae, G., Nerenberg, C., Worden, A., Foreman, J., Hwang, J. Y., Kushinsky, S., Jones, R. E. and Vickery, B., Nasal absorption of Nafarelin acetate, the decapeptide [D-Nal(2)6]LHRH, in rhesus monkeys I.J. Pharm. Sci., 73(5), 684–685 (1984).
2. Aungst, B. J., Rogers, N. J. and Shefter, E., Comparison of nasal, rectal, buccal, sublingual and intramuscular insulin efficacy and the effects of a bile salt absorption promoter.J. Pharmacol. Exp. Ther., 244, 23–27 (1988).
3. Brogden, R. N., Buckley, M. M. and Ward, A., Buserelin. A review of its pharmacodynamic and pharmacokinetic properties, and clinical profile.Drugs, 39(3), 399–437(1990).
4. Han, K. and Park, J. S., Transmucosal delivery of luteinizing hormone-releasing hormone: Effect of medium chain fatty acid salts on stabilization of LHRH in mucosal homogenatesin vitro.Yakhak Hoeji, 38, 67–77 (1994).
5. Hirai, S., Yashiki, T. and Mima, H., Mechanisms for the enhancement of the nasal absorption of insulin by surfactants.Int. J. Pharm., 9, 173–184 (1981).